The preferred order of over-the-counter (OCT) pharmaceutical label components

Drug Information Journal

Volumn 31, Issue 3, 1997, Pages 973-988

  Vigilante Jr , William J ^a   Wogalter, Michael S ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Component ordering; Consumer preference; Nonprescription medication; Warnings

Indexed keywords

CALCIUM BROMOLACTATE; CLEMASTINE FUMARATE; CYCLIZINE; NEW SKIN; NON PRESCRIPTION DRUG; UNCLASSIFIED DRUG;

ARTICLE; CONSUMER; DRUG INDICATION; DRUG LABELING; DRUG SAFETY; DRUG STORAGE; DRUG USE; EMERGENCY; PRIORITY JOURNAL; PURCHASING; STANDARDIZATION;

EID: 1842328037     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100341     Document Type: Article

References (26)

1. U.S. Food and Drug Administration. Public Hearing on Over-the-Counter Drug Labeling, Washington, DC, Sept. 29, 1995.
2. Federal Register. 1991: Vol. 56, no 229, Nov. 27. Dept. of Agriculture, Food Safety and Inspection Service.
3. Wogalter MS, Kalsher MJ, Litynski DM. Influence of food label quantifier terms on connoted amount and purchase intention. Proceedings of the Human Factors and Ergonomics Society 40th Annual Meeting. 1996.
4. ANSI. American National Standard for Safety Warnings. Washington DC: American National Standards Institute; 1991.
5. Wogalter MS, Kalsher MJ. Product label list format of item arrangement and completeness on comparison time and accuracy. Proceedings of the Human Factors and Ergonomics Society 38th Annual Meeting. 1994;389-393.
6. Somberg BL. A comparison of rule-based and positionally constant arrangement of computer menu items. Chi 1987 Proceedings. 1987;150-153.
7. Tullis TS. Predicting the usability of alphanumeric displays. Ph.D. dissertation, Rice University; 1984.
8. Schneider W, Shiffrin RM. Controlled and automatic human information processing: I. Detection, search, and attention. Psychol Rev. 1977;1-66.
9. Engle JP. Testimony of the American Pharmaceutical Association: FDA Public Hearing on Over-the-Counter Drug Labeling, Sept. 29, 1995.
10. Testimony of the Non-Prescription Drug Manufacturers Association: FDA Public Hearing on Over-the-Counter Drug Labeling. Sept. 29, 1995.
11. Federal Register. 1997: Vol. 62, no 39, Feb. 27. Over-the-Counter Human Drugs: Proposed Labeling Requirements. Food and Drug Administration.
12. Wogalter MS, Dietrich DA. Enhancing label readability for over-the-counter pharmaceuticals by elderly consumers. Proceedings of the Human Factors and Ergonomics Society 39th Annual Meeting. 1995; 143-147.
13. Frantz JP. Effect of location and procedural explicitness on user processing of and compliance with product warnings. Human Factors. 1994;36(3):532-546.
14. Wogalter MS, Godfrey S, Fontenelle G, Desaulniers D, Rothstein P, Laughery, K. Effectiveness of warnings. Human Factors. 1987;29(5):599-612.
15. Strawbridge JA. The influence of position, highlighting, and imbedding on warning effectiveness. Proceedings of the Human Factors and Ergonomics Society 30th Annual Meeting. 1988;716-720.
16. Showers LS, Celuch KG, Lust JA. Consumers' use of product owner manuals. Advanc Consumer's Interest. 1992;4(1):22-28.
17. Lust JA, Celuch KG, Showers L. An investigation of the effects of placement of obvious warnings and safety warning format in product manuals. Proceedings of the Marketing and Public Policy Conference. Atlanta: Georgia State University; 1995:11-20.
18. Vigilante WJ Jr, Wogalter MS. On the prioritization of safety warnings in product manuals. Int J Ind Ergonomics. In press.
19. Morrow DG, Leirer VO, Altieri P, Tanke ED. Elders' schema for taking medication: implications for instruction design. J Gerontol. 1991;46:378-385.
20. Morrow DG, Leirer VO, Andrassy JM, Tanke ED, Stine-Morrow EAL. Medication instruction design: Younger and older adult schmas for taking medications. Human Factors. 1996;38(4):556-573.
21. Morrow, DG, Leirer VO, Sheikh J. Adherence and medication instructions: Review and recommendations. J Am Geriatric Soc. 1988;36:1147-1160.
22. Watanabe RK. The ability of the geriatric population to read labels on over-the-counter medication bottles. J Am Optometric Assoc. 1994;65:32-37.
23. Wogalter MS, Magurno A, Scott K, Dietrich DA. Facilitating information acquisition for over-the-counter drugs using supplemental labels. Proceedings of the Human Factors and Ergonomics Society 40th Annual Meeting. 1996;732-736.
24. Godfrey SS, Allender L, Laughery KR, Smith VL. Warning messages: Will the consumer bother to look? Proceedings of the Human Factors Society 27th Annual Meeting. 1983;950-954.
25. Wogalter MS, Breisford JW, Desaulniers DR, Laughery KR. Consumer product warnings: The role of hazard perception. J Safety Res. 1991;22:71-82.
26. Vigilante WJ Jr, Wogalter MS. The ordering of over-the-counter pharmaceutical label components. Proceedings of the Human Factors and Ergonomics Society 40th Annual Meeting. 1996;141-145 .